Sonnet BioTherapeutics Holdings, Inc. Profile Avatar - Palmy Investing

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human sin…

Biotechnology
US, Princeton [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Sonnet BioTherapeutics Holdings, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Sonnet BioTherapeutics Holdings, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Sonnet BioTherapeutics Holdings, Inc..

End of SONN's Analysis
CIK: 1106838 CUSIP: 83548R105 ISIN: US83548R3030 LEI: - UEI: -
Secondary Listings
SONN has no secondary listings inside our databases.